Neogen Corp
Neogen Corporation (NEOG) supplies testing, products and services aimed at food and animal safety. The company sells diagnostic kits, sanitising and lab equipment, veterinary instruments and related consumables to food processors, retailers and animal-health customers. With a market capitalisation around $1.28bn, Neogen operates in a specialist niche where regulatory standards, outbreak prevention and quality assurance drive demand. Growth has come from product development and selective acquisitions, giving scale in both testing technologies and consumables. Investors should note the business can be cyclical with exposure to food-industry spending and margins influenced by raw‑material and integration costs. This summary is general educational information, not personalised advice — stocks can fall as well as rise, and suitability depends on your financial situation and risk tolerance.
Stock Performance Snapshot
Analyst Rating
Analysts suggest buying Neogen Corp's stock, expecting its value to rise to $7.63.
Financial Health
Neogen Corp is performing well with strong revenue and profits, indicating healthy financial stability.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring NEOG
Next-Gen Proteins
Looking to invest in the future of food? This carefully selected group of stocks represents companies solving our global protein challenges. From plant-based alternatives to agricultural innovation, these stocks have been thoughtfully chosen by our analysts for their potential in this growing market.
Published: June 17, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Recurring Consumables Demand
A sizeable portion of sales are repeat consumables and reagents, which can provide revenue durability — though volumes may vary with industry spending.
Regulation Supports Need
Tighter food‑safety rules and globalisation of supply chains can increase demand for testing and traceability, yet regulatory shifts can also change buyer behaviour.
Product & Acquisition Strategy
Neogen grows through new diagnostics and selective acquisitions that expand capabilities and distribution, but integration and margin effects warrant attention.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Abbott Laboratories
Abbott Laboratories is a global healthcare company that develops and markets a broad range of health care products, including medical devices, diagnostics, nutritionals, and branded generic pharmaceuticals.
Agilent Technologies Inc.
Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. Life Sciences and Diagnostics Markets segment comprises seven areas of activity. It offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. Agilent CrossLab segment offers a services and consumables portfolio that spans the entire lab, in addition to software and laboratory automation solutions, which are designed to enhance customer outcomes. Applied Markets segment offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products.
Align Technology Inc.
Align Technology is a medical device company that designs, manufactures and markets a range of dental and orthodontic products.
